Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471792 · ClinicalTrials.gov registry record · Phase 2
Creatine Use and Muscle Stretching in Peripheral Artery Disease
A Phase 2 study, sponsored by Florida State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT04471792 is a Phase 2 study that has completed, run by Florida State University. The registered enrollment target is 13 participants.
The verdict
NCT04471792, a Phase 2 study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
To utilize near-infrared spectroscopy to investigate if the research device, which induces muscle stretching, and creatine loading impact submaximal exercise performance in aged and PAD patients. Near-infrared spectroscopy (NIRS)-derived tissue oxygenation responses will be obtained during device placement (muscle stretch) and during a walking test (i.e., six-minute walk test). Muscle oxygenation at rest and during device placement will be assessed with Magnetic Resonance Imaging. It is hypothesized that the stretching protocol will improve both NIRS-derived tissue oxygenation and magnetic resonance-derived muscle oxygenation and that creatine supplementation will further improve phosphorus metabolite muscle performance. All patients will undergo either 4 weeks of stretch training with- or- without creatine supplementation according to previously defined creatine guidelines.
Interventions
- DRUG Creatine monohydrate
- DIETARY_SUPPLEMENT Cellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-05-12 |
| Est. Completion | 2022-12-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471792
The ClinicalTrials.gov registry entry for NCT04471792 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Creatine monohydrate is the first listed.
NCT04471792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04471792 about?
NCT04471792 is a clinical study titled "Creatine Use and Muscle Stretching in Peripheral Artery Disease". To utilize near-infrared spectroscopy to investigate if the research device, which induces muscle stretching, and creatine loading impact submaximal exercise performance in aged and PAD patients. Near-infrared spectroscopy (NIRS)-derived tissue oxygenation responses will be obtained during device pl...
What is the current status of trial NCT04471792?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2020-05-12. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT04471792?
The interventions under investigation include: Creatine monohydrate (DRUG), Cellulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04471792?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.